Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

388 ARTÍCULOS , VIENDO DEL 361 AL 375

Impact of AP@LZ in the daily life of three persons with Alzheimer's disease: long-term use and further exploration of its effectiveness

Imbeault H, Gagnon L, Pigot H, Giroux S, Marcotte N, Cribier-Delande P, Duval J, Bocti C, Lacombe G, Fülöp T, Bier N.

Neuropsychol Rehabil. 2018 Jul;28(5):755-778. doi: 10.1080/09602011.2016.1172491. Epub 2016 Apr 28.

A life-course and multifactorial approach to Alzheimer's disease: Implications for research, clinical assessment and intervention practices

Van der Linden M, Juillerat Van der Linden AC.

Dementia (London). 2018 Oct;17(7):880-895. doi: 10.1177/1471301216657270. Epub 2016 Jun 27.

Incontinence in nursing home residents with dementia : Influence of an educational program and nursing case conferences

Kohler M, Schwarz J, Burgstaller M, Saxer S.

Z Gerontol Geriatr. 2018 Jan;51(1):48-53. doi: 10.1007/s00391-016-1120-3. Epub 2016 Sep 6.

[Non-pharmacological treatment of dementia in geriatric psychiatry care units : Scoping review]

Göhner A, Hüll M, Voigt-Radloff S.

Z Gerontol Geriatr. 2018 Feb;51(2):169-183. doi: 10.1007/s00391-016-1161-7. Epub 2016 Dec 16.

Cognitive Impairment, Alzheimer's Disease, and Other Dementias in the Lives of Lesbian, Gay, Bisexual and Transgender (LGBT) Older Adults and Their Caregivers: Needs and Competencies

Fredriksen-Goldsen KI, Jen S, Bryan AEB, Goldsen J.

J Appl Gerontol. 2018 May;37(5):545-569. doi: 10.1177/0733464816672047. Epub 2016 Oct 10.

The role of neuropathological markers in the interpretation of neuropsychiatric disorders: Focus on fetal and perinatal programming

Fanni D, Gerosa C, Rais M, Ravarino A, Van Eyken P, Fanos V, Faa G.

Neurosci Lett. 2018 Mar 16;669:75-82. doi: 10.1016/j.neulet.2016.10.063. Epub 2016 Nov 3.

Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein

Folch J, Ettcheto M, Petrov D, Abad S, Pedrós I, Marin M, Olloquequi J, Camins A.

Neurologia (Engl Ed). 2018 Jan-Feb;33(1):47-58. doi: 10.1016/j.nrl.2015.03.012. Epub 2015 May 11.

The potential of virtual reality-based training to enhance the functional autonomy of Alzheimer's disease patients in cooking activities: A single case study

Foloppe DA, Richard P, Yamaguchi T, Etcharry-Bouyx F, Allain P.

Neuropsychol Rehabil. 2018 Jul;28(5):709-733. doi: 10.1080/09602011.2015.1094394. Epub 2015 Oct 20.

Fornical Closed-Loop Stimulation for Alzheimer's Disease

Senova S, Chaillet A, Lozano AM.

Trends Neurosci. 2018 Jul;41(7):418-428. doi: 10.1016/j.tins.2018.03.015. Epub 2018 May 4.

Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach

Trompetero A, Gordillo A, Del Pilar MC, Cristina VM, Bustos Cruz RH.

Curr Pharm Des. 2018;24(1):22-45. doi: 10.2174/1381612823666170828133059.

Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models

Hölscher C.

Neuropharmacology. 2018 Jul 1;136(Pt B):251-259. doi: 10.1016/j.neuropharm.2018.01.040. Epub 2018 Jan 31.

Current Limitations in the Treatment of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers

Tonda-Turo C, Origlia N, Mattu C, Accorroni A, Chiono V.

Curr Med Chem. 2018;25(41):5755-5771. doi: 10.2174/0929867325666180221125759.

Role of Plant-Derived Flavonoids and Their Mechanism in Attenuation of Alzheimer's and Parkinson's Diseases: An Update of Recent Data

Hussain G, Zhang L, Rasul A, Anwar H, Sohail MU, Razzaq A, Aziz N, Shabbir A, Ali M, Sun T.

Molecules. 2018 Apr 2;23(4):814. doi: 10.3390/molecules23040814.

Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics

Pan Y, Nicolazzo JA.

Adv Drug Deliv Rev. 2018 Oct;135:62-74. doi: 10.1016/j.addr.2018.04.009. Epub 2018 Apr 14.

A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia

Knight R, Khondoker M, Magill N, Stewart R, Landau S.

Dement Geriatr Cogn Disord. 2018;45(3-4):131-151. doi: 10.1159/000486546. Epub 2018 May 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias